EYPT CIK: 1314102

EyePoint, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.1
FY22:
−65.0
FY23:
1.88
FY24:
−126
FY25:
−240
Change from FY21 to FY25
millions USD
FY21:
−33.1
FY22:
−17.3
FY23:
−3.32
FY24:
−219
FY25:
68.6
Change from FY21 to FY25
millions USD
FY21:
217
FY22:
−0.69
FY23:
187
FY24:
164
FY25:
174
millions USD
FY21:
134
FY22:
−83.0
FY23:
186
FY24:
−182
FY25:
2.12
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.3
FY22:
−67.2
FY23:
−1.61
FY24:
−130
FY25:
−243

All amounts in millions USD Data source:SEC EDGAR